We are live on ! Find out more
CFM

Catalyst Funds Management Portfolio holdings

AUM $591M
1-Year Est. Return 71.09%
This Fund
S&P 500
This Quarter Est. Return
-3.7%
1 Year Est. Return
+71.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$382M
AUM Growth
-$26.8M
Cap. Flow
-$3.95M
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.96%
Holding
611
New
314
Increased
64
Reduced
61
Closed
163

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$15.4M
2
PFE icon
Pfizer
PFE
+$7.4M
3
BLK icon
Blackrock
BLK
+$5.25M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.93M
5
RYAAY icon
Ryanair
RYAAY
+$4.84M

Sector Composition

Rank Sector Weight
1 Financials 17.99%
2 Technology 14.82%
3 Industrials 13.5%
4 Healthcare 12.31%
5 Consumer Discretionary 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RZLT icon
426
Rezolute
RZLT
$476M
$31.3K 0.01%
+10,779
New +$46.9K
ORGN
427
DELISTED
Origin Materials
ORGN
$30.7K 0.01%
1,544
+544
+54% +$15K
USAS
428
Americas Gold and Silver
USAS
$1.37B
$30.4K 0.01%
23,040
GNLX icon
429
Genelux
GNLX
$132M
$30.3K 0.01%
+11,238
New +$42.2K
DOUG icon
430
Douglas Elliman
DOUG
$158M
$30.3K 0.01%
+17,635
New +$31.9K
IKT icon
431
Inhibikase Therapeutics
IKT
$369M
$30K 0.01%
+13,712
New +$34.4K
VUZI icon
432
Vuzix
VUZI
$193M
$29.2K 0.01%
14,300
+2,300
+19% +$7.53K
ZVIA icon
433
Zevia
ZVIA
$113M
$27.4K 0.01%
+12,707
New +$41.6K
RLAY icon
434
Relay Therapeutics
RLAY
$4.06B
$26.5K 0.01%
+10,100
New +$39.6K
ACRS icon
435
Aclaris Therapeutics
ACRS
$750M
$25.5K 0.01%
16,698
+2,698
+19% +$5.75K
GNSS icon
436
Genasys
GNSS
$74.2M
$23.8K 0.01%
+10,496
New +$29.1K
ANNX icon
437
Annexon
ANNX
$841M
$22.7K 0.01%
+11,760
New +$39.1K
ALLO icon
438
Allogene Therapeutics
ALLO
$604M
$21.3K 0.01%
+14,580
New +$27.5K
ILLR
439
Triller Group Inc
ILLR
$22.5M
$21.1K 0.01%
+2,707
New +$40.8K
ALTO icon
440
Alto Ingredients
ALTO
$349M
$20K 0.01%
+17,557
New +$27.2K
SMRT icon
441
SmartRent
SMRT
$186M
$18.7K ﹤0.01%
15,428
-12,572
-45% -$17.6K
TSHA icon
442
Taysha Gene Therapies
TSHA
$1.59B
$16.5K ﹤0.01%
+11,900
New +$19.9K
KOPN icon
443
Kopin
KOPN
$687M
$16.5K ﹤0.01%
+17,710
New +$26K
MVIS icon
444
Microvision
MVIS
$88.8M
$12.5K ﹤0.01%
+10,100
New +$14.1K
VXRT
445
DELISTED
Vaxart
VXRT
$10.9K ﹤0.01%
+26,742
New +$17.2K
SENS icon
446
Senseonics Holdings Inc
SENS
$262M
$10.1K ﹤0.01%
+770
New +$12.7K
BW icon
447
Babcock & Wilcox
BW
$1.4B
$9.74K ﹤0.01%
14,484
-516
-3% -$638
VOR icon
448
Vor Biopharma
VOR
$1.05B
$7.72K ﹤0.01%
+538
New +$12.9K
A icon
449
Agilent Technologies
A
$38.9B
-2,600
Closed -$349K
AAOI icon
450
Applied Optoelectronics
AAOI
$7.85B
-6,200
Closed -$229K

Similar funds

Catalyst Funds Management's Q1 2025 Portfolio in Review

As of Q1 2025, Catalyst Funds Management held 611 positions worth $382M, down 6.6% from $409M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Catalyst Funds Management's Q1 2025 filing shows 314 new, 64 increased, 61 reduced and 163 closed positions. Its largest new stake was NVIDIA: 121,200 shares worth $13.1M. The largest sale was Broadcom, an estimated $35.5M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • Catalyst Funds Management's largest Q1 2025 buy was NVIDIA: 121,200 shares worth $13.1M.
  • Catalyst Funds Management added most to Blackrock in Q1 2025, an estimated $5.25M increase.
  • Catalyst Funds Management's biggest Q1 2025 reduction was Coca-Cola Europacific Partners, cutting an estimated $10M.
  • Catalyst Funds Management fully exited Broadcom in Q1 2025, selling an estimated $35.5M.
  • Catalyst Funds Management's ten largest holdings make up 19% of its $382M portfolio in Q1 2025.
  • Catalyst Funds Management opened 314 new positions and closed 163 in Q1 2025.
  • Catalyst Funds Management's portfolio value fell 6.6% quarter-over-quarter to $382M.

Based on Catalyst Funds Management's 13F filing for Q1 2025, filed 14 May 2025.